AI–scientist collaboration ↗
An editorial connection between questions, not a claim that the studies demonstrate the same mechanism or outcome.
Frozen card revision. This is the recorded reading, not an automatically refreshed view. Current card ↗
Commercialization · TOPIC v2
After AI Finds a Candidate, What Gets Paid For?
After a candidate is found, how far is it validated, and who retains rights to the results?
Read article → After AI Finds a Candidate, What Gets Paid For?
2026-09-29 15:11:40.000 UTC · Last recorded update
CURRENT READING
ART function remains unknown. The article compares experimental services, joint discovery and contractual options exercised after validation.
Recorded editorial state, not a maturity score
- Reports and agreements reviewedRecorded
- Further validationUnverified
- Adoption and benefitUnverified
Analysis added · v1 → 2
Added ART and Recursion cases to compare experimental services with rights to resulting assets.
Permanent link to this revision ↗01 / WHAT WE TRACK
After a candidate is found, how far is it validated, and who retains rights to the results?
02 / EVIDENCE & TECHNOLOGY
Sequence discovery AI / experimental services / joint drug discovery
03 / EDITORIAL READING
Completing an assay and assembling evidence for a development decision have different returns and risks.
04 / WHAT REMAINS UNKNOWN
More AI candidates do not guarantee more experiments or profit. Entry into drug discovery is not clinical efficacy.
05 / NEXT CHECK
Functional validation, contract terms, asset rights and allocation of failure risk.
A hypothesis to keep honest
HYPOTHESIS · NOT YET TESTEDAssembling decision-ready evidence and retaining rights may generate returns beyond fees for work performed.
What would change our view: Reconsider if validation costs and failure risk outweigh fees or the value of retained rights.
A prospective test proposal, not a prediction score. A graph connection does not validate this hypothesis.
Linked people & organizations
Open an entity to find its cardsCOMPANYGinkgo Bioworks ↗
Who earns the returns from testing scientific AI predictions and developing the results?
COMPANYSchrödinger ↗
Who earns the returns from testing scientific AI predictions and developing the results?
COMPANYTectora Therapeutics ↗
Who earns the returns from testing scientific AI predictions and developing the results?
INSTITUTION / INFRASTRUCTUREAnthropic ↗
Mentioned in this issue
INSTITUTION / INFRASTRUCTUREART enzyme system ↗
Mentioned in this issue
INSTITUTION / INFRASTRUCTUREEmerald Cloud Lab ↗
Mentioned in this issue
INSTITUTION / INFRASTRUCTURENovartis ↗
Mentioned in this issue
INSTITUTION / INFRASTRUCTURERecursion ↗
Mentioned in this issue
Related questions, optional follows
Map ↗What Does Chugai Still See in a Drug Roche Is Walking Away From? ↗
A business comparison of who holds asset rights and bears development costs.
Latest card updates
Latest 5 · editorial record dates- v2 · 2026-09-29 15:11:40.000 UTCAnalysis added
Added ART and Recursion cases to compare experimental services with rights to resulting assets.
Reading at the time: ART function remains unknown. The article compares experimental services, joint discovery and contractual options exercised after validation.
- v1 · 2026-09-23 09:08:41.974 UTCNew question opened
Published the analysis and recorded the next checks.
Reading at the time: Ginkgo announced experimental-services and in-house laboratory partnerships. Schrödinger contributed two drug programs to Tectora.
Earlier updates (0)
Earlier entries will appear here once more than five reader-facing revisions have accumulated.
Background readings
Source dates and verification scope
Ginkgo発表・配信転載 ↗
www.tmcnet.com · accessed 2026-09-23 · public-source
Ginkgo発表・無編集転載 ↗
www.marketscreener.com · accessed 2026-09-23 · public-source
Schrödinger公式発表 ↗
ir.schrodinger.com · accessed 2026-09-23 · public-source
公式発表 ↗
www.anthropic.com · recorded 2026-09-29 · linked-primary-source
公式料金体系 ↗
www.emeraldcloudlab.com · recorded 2026-09-29 · linked-primary-source
契約発表 ↗
ir.schrodinger.com · recorded 2026-09-29 · linked-primary-source
Tectoraの発表 ↗
ir.schrodinger.com · recorded 2026-09-29 · linked-primary-source
共同研究の進展 ↗
ir.recursion.com · recorded 2026-09-29 · linked-primary-source